The antioxidative property of green tea against iron-induced oxidative stress in rat brain

Chinese Journal of Physiology

Volumn 41, Issue 4, 1998, Pages 189-194

  Lin, Anya M Y ^a   Chyi, B Y ^a   Wu, L Y ^b   Hwang, L S ^b   Ho, L T ^a,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Antioxidant; Green tea; Iron; Lipid peroxidation; Nigrostriatal system; Oxidative stress

Indexed keywords

IRON; MALONALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN INJURY; BRAIN PROTECTION; CONTROLLED STUDY; CORPUS STRIATUM; DEMYELINATING DISEASE; LIPID PEROXIDATION; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OXIDATIVE STRESS; RAT; SUBSTANTIA NIGRA; TEA;

EID: 0032429337     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ames B.N., M. K. Shigenaga, and T. M. Hagen. Oxidants, antioxidants and the degenerative disease of aging. Proc. Natl. Acad. Sci. USA. 90: 7915-7922, 1993.
2. Ben-Shachar D., and M.B.H. Youdim. Intranigral iron injection induces behavioral and biochemical "Parkinsonism" in rats. J. Neurochem. 57: 2133-2135, 1991.
3. Chiueh C.C., Z. Zukowaka-Grojec, K.L. Kirk, and I.J. Kopin. 6-Fluorocatecholamines as false adrenergic neurotransmitters. J. Pharmacol. Exp. Ther. 225: 529-533, 1983.
4. Cohen G., and P. Werner. Free radicals, oxidative stress and neurodegeneration, in Neurodegenerative Diseases (Calne D.B., ed.), WB Saunders, Philadelphia. 1994, pp. 139-162.
5. Dexter D.T., A.E. Holly, W.D. Flitter, T.F. Slater, F.R. Wells, S. E. Daniel, A.J. Lees, P. Jenner, and D. C. Marden. Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. Move. Disor. 9: 92-97, 1994a.
6. Dexter D.T., F.R. Wells, A.J. Lees, F. Agid, Y. Agid, P. Jenner and C.D. Marsden Increased nigral iron content and alteration in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 52: 1830-1836, 1994b.
7. Ebadi M., S. K. Srinivasan, and M.D. Baxi. Oxidative stress and antioxidant therapy in Parkinson's disease. Prog. Neurobiol. 48: 1-19, 1996.
8. Guo Q., B. Zhao, M., Li, S. Shen, and W. Xin. Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochimica et Biophysica Acta 1304: 210-222, 1996.
9. Halliwell B. and J.M. Gutteridge. Oxygen toxicity, oxygen radicals, transition metals and diseases. Biochem. J. 219: 1-14, 1984.
10. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59: 1609-1623, 1992.
11. Hirsch E. C. Does oxidative stress participate in nerve cell death in Parkinson's disease? Eur. Neurol. 1: 52-59, 1993.
12. Huang MT., CT. Ho, ZY. Wang, T. Ferraro, T. Finnegan-Olive, YR. Lou, JM. Mitchell, J.D. Laskin, H. Newmark, C.S. Yang, and A. Conney. Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin. Carcinogenesis 13: 947-954, 1992.
13. Ishikawa T., M. Suzukawa, K. Ito, H. Yoshida, M. Ayaori, M. Nishiwaki, A. Yonemura, Y. Hara and H. Nakamura. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am. J. Clin. Nutr. 66 261-266, 1997.
14. Jenner P. and C.W. Olanow. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47: S161-170, 1996.
15. Katiyar SK., R. Agarwal, and H. Mukhtar. Protection against malignant conversion of chemically induced benign skin papillomas to squamous cell carcinomas in SENCAR mice by a polyphenolic fraction isolated from green tea. Cancer Res. 53: 5409-5412, 1993.
16. Kikugawa K., T. Kato, M. Beppu, and A. Haysaaka. Fluorescent and crosslinked protein formed by free radical and aldehyde species generated during lipid peroxidation. Adv. Exper. Med. Biol. 266: 345-356, 1989.
17. Leanderson P., A.O. Faresjo, and C. Tagesson. Green Tea polyphenols inhibits oxidant-induced DNA strand breakage in cultured lung cells. Free Rad. Biol. Med. 23:235-242, 1997.
18. Lin A.M.Y., C.H. Yang, and C.Y. Chai. Striatal dopamine dynamics are altered following an intranigral infusion of iron in SD rat. Free Rad. Biol. Med., 24: 988-993 1998.
19. Mokanakumar K.P., A. DeBartolomeis, R.M. Wu, K.J. Yeh, L.M. Sternberger, S. Peng, D.L. Murphy, and C.C. Chiueh. Ferrous citrate complex and nigral degeneration: evidence for free radical formation and lipid peroxidation. Ann. N. Y. Acad. Sci. 738: 392-399, 1994.
20. Noda Y., K. Anzai, A. Mori, M. Kohno, M. Shinmei, and L. Packer. Hydroxyl and superoxide anion radical scavenging activities of natural source antioxidants using the computerized JES-FR30 ESR spectrometer system. Biochem. Mol. Biol. Intern., 42: 34-44, 1997.
21. Packer L., E.H. Wit and H.J. Tritscher. α-Lipoic acid as a biological antioxidant. Free Radic Biol. Med. 19: 227-250, 1995.
22. Paxinos G., and C. Watson. The rat brain in stereotaxic coordinates, Academic Press, New York, 1986.
23. Perry T. L., D.V. Godin and A. Hansen. Parkinson's disease: a disorder due to nigral glutathione deficiency. Neurosci. Lett. 33: 305-310, 1982.
24. Rauhala P., K. Parameswarannay, I. Sziraki, A.M.Y. Lin, and C.C. Chiueh. S-nitrosothiols and nitric oxide, but not sodium nitroprusside protect nigrostriatal dopamine neurons against iron-induced oxidative stress in vivo. Synapse 23: 58-60 1996.
25. Rauhala P., A.M.Y. Lin, and C.C. Chiueh. Neuroprotection by s-nitrosoglutathione of brain dopamine neurons from oxidative stress. FASEB. 12: 165-173, 1998.
26. Sengstock G.J., C.W. Olanow, A.J. Dunn, S. jr. Barone, and G.W. Arendash. Progressive changes in striatal dopaminergic markers, nigral volume, and rotational behavior following iron infusion into the rat substantia nigra. J. Neurology 130: 82-94, 1994.
27. Sofic E., W. Paulus, K. Jellinger, P. Riederer, and M.B.H. Youdim. Selective increase of iron in substantia nigra zona compacta of Parkinsonian brains. J. Neurochem. 56: 978-982, 1991.
28. Sofic E., K.W. Lang, K. Jellinger, and P. Riederer. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci. Lett. 142: 128-130, 1992.
29. Stensvold I, A. Tverdal, K. Solvoll, and O.P. Foss. Tea consumption, relationship to cholesterol, blood pressure and coronary and total mortality. Preventive Medicine 21: 546-553, 1992.
30. Tijburg L.B., S.A. Wiseman, G.W. Meijer, and J.A. Weststrate. Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolaemic rabbits. Atherosclerosis 135: 37-47, 1997.
31. de la Torre M.R., A. Casado, M.E. Lopez-Fernandez, D. Carrascosa, M.C. Casado, D. Venarucci and V. Venarucci. Human aging brain disorders: role of antioxidant enzymes. Neurochem. Res. 21: 885-888, 1996.
32. Wang ZY., M.T. Huang, C.T. Ho, R. Chang, W. Ma, T. Ferraro, K.R. Reuhl, C.S. Yang and A.H. Conney. Inhibitory effect of green tea on the growth of established skin papillomas in mice. Cancer Res. 52: 6657-6665, 1992.
33. Youdim M. B., D. Ben-Shachar, G. Eshel, J.P.M., Finberg and P. Riederer. The neurotoxicity of iron and nitric oxide relevance to the etiology of Parkinson's disease, in Adv. Neurol. (Narabyashi H., Nagatsu T., Yanagisawa N., and Mizuno Y., eds), 1993, pp. 259-266. Raven Press, New York.
34. Zhang A., Q.Y. Zhu, Y.S. Luk, K.Y. Ho, K.P. Fung, and Z.Y. Chen. Inhibitory effects of Jasmine green tea epicatechin isomers on free radicals-induced lysis of red blood cells. Life Sci. 61: 383-394, 1997.
35. Zhao BL, XJ. Li, R.G. He, S.J. Cheng, and W.J. Xin. Scavenging effect of extract of green tea and natural antioxidants on active oxygen radicals. Cell Biophysics. 14: 175-185, 1989.